miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma

Biomarkers to guide the clinical treatment of patients with renal cell carcinoma (RCC) are not yet routinely available. MicroRNAs (miRNAs) have been demonstrated to serve as biomarkers for a number of types of cancer. Based on a previous study by this group, we hypothesize that several highly differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuanyu, Lou, Ning, Ruan, Anming, Qiu, Bin, Yan, Yun, Wang, Xuegang, Du, Quansheng, Ruan, Hailong, Han, Weiwei, Wei, Haibin, Yang, Hongmei, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036413/
https://www.ncbi.nlm.nih.gov/pubmed/30008851
http://dx.doi.org/10.3892/ol.2018.8874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036413/
https://www.ncbi.nlm.nih.gov/pubmed/30008851
http://dx.doi.org/10.3892/ol.2018.8874

Ejemplares similares